Cargando…
In silico molecular docking of SARS-CoV-2 surface proteins with microbial non-ribosomal peptides: identification of potential drugs
Outbreak of COVID-19 by SARS-CoV-2 infection caused severe acute respiratory syndrome that has been declared a public health emergency of international concern. To control infections, there is urgent need to develop an effective therapeutic strategy. COVID-19 viral spike glycoprotein and proteases p...
Autores principales: | Bansal, Poonam, Kumar, Raman, Singh, Jasbir, Dhanda, Suman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385692/ https://www.ncbi.nlm.nih.gov/pubmed/34456530 http://dx.doi.org/10.1007/s42485-021-00072-z |
Ejemplares similares
-
In-silico study of peptide-protein interaction of antimicrobial peptides potentially targeting SARS and SARS-CoV-2 nucleocapsid protein
por: Bansal, Ritu, et al.
Publicado: (2021) -
In Silico Identification of Potential Inhibitors of the SARS-CoV-2 Nucleocapsid Through Molecular Docking-Based Drug Repurposing
por: Afreen, Rukhsar, et al.
Publicado: (2022) -
Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern
por: Shahhosseini, Nariman, et al.
Publicado: (2021) -
Activity Staining and Inhibition Characterization of Dipeptidylpeptidase-III Enzyme from Goat Brain
por: Attri, Pooja, et al.
Publicado: (2011) -
In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2
por: Chidambaram, Sathish Kumar, et al.
Publicado: (2020)